Aggressive estrogen-receptor-positive breast cancer arising in patients with elevated body mass index

Verfasser / Beitragende:
[Cesar Santa-Maria, Jingsheng Yan, Xian-Jin Xie, David Euhus]
Ort, Verlag, Jahr:
2015
Enthalten in:
International Journal of Clinical Oncology, 20/2(2015-04-01), 317-323
Format:
Artikel (online)
ID: 605491917
LEADER caa a22 4500
001 605491917
003 CHVBK
005 20210128100512.0
007 cr unu---uuuuu
008 210128e20150401xx s 000 0 eng
024 7 0 |a 10.1007/s10147-014-0712-4  |2 doi 
035 |a (NATIONALLICENCE)springer-10.1007/s10147-014-0712-4 
245 0 0 |a Aggressive estrogen-receptor-positive breast cancer arising in patients with elevated body mass index  |h [Elektronische Daten]  |c [Cesar Santa-Maria, Jingsheng Yan, Xian-Jin Xie, David Euhus] 
520 3 |a Background: Obese women with estrogen receptor (ER)-positive breast cancer may experience worse disease-free and overall survival. We hypothesize that this observation is due to intrinsically aggressive disease and that obesity will be associated with higher histologic grade and Ki67. Methods: A sequential cohort of women with breast cancer diagnosed over 2years was assembled from institutional tumor registries. Patient and tumor characteristics were abstracted from medical records; those with non-invasive tumors, or lacking body mass index (BMI), Ki67 or histologic grade data, were excluded. Univariate and multivariate analysis was performed to investigate the relationship between markers of aggressive disease (grade and Ki67) and multiple variables associated with obesity. A subgroup analysis was performed to investigate further whether ER and menopausal status influenced associations between BMI and aggressive phenotypes. Results: Of the 1007 patients initially identified, 668 (68%) met the eligibility criteria. In univariate analysis, histologic grade and Ki67 were strongly associated with increased BMI, younger age, and African-American race, but less so with diabetes, hypertension, and hyperlipidemia. Multivariate analysis confirmed that higher histologic grade was associated with increased BMI (p=0.02), and that increased Ki67 was associated with younger age (p=0.0003) and African-American race (p=0.002). Additional analysis found that the association between increased BMI and higher-grade tumors was particularly significant in premenopausal women with ER-positive disease. Conclusion: This study concludes that increased BMI is associated with aggressive-phenotype breast cancer and may be particularly relevant to ER-positive breast cancer developing in premenopausal African-American women. 
540 |a Japan Society of Clinical Oncology, 2014 
690 7 |a Breast cancer  |2 nationallicence 
690 7 |a Obesity  |2 nationallicence 
690 7 |a Aggressive phenotype  |2 nationallicence 
690 7 |a Histologic grade  |2 nationallicence 
690 7 |a Ki67  |2 nationallicence 
700 1 |a Santa-Maria  |D Cesar  |u Department of Medical Oncology, Sidney Kimmel Comprehensive Cancer Center, Bunting-Blaustein Cancer Research Bldg, Johns Hopkins University, 1650 Orleans St., Rm. 144, 21287-0013, Baltimore, MD, USA  |4 aut 
700 1 |a Yan  |D Jingsheng  |u Department of Clinical Sciences, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, 75390-8551, Dallas, TX, USA  |4 aut 
700 1 |a Xie  |D Xian-Jin  |u Department of Clinical Sciences, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, 75390-8551, Dallas, TX, USA  |4 aut 
700 1 |a Euhus  |D David  |u Department of Surgery, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, 600 N. Wolfe Street, 21287, Baltimore, MD, USA  |4 aut 
773 0 |t International Journal of Clinical Oncology  |d Springer Japan  |g 20/2(2015-04-01), 317-323  |x 1341-9625  |q 20:2<317  |1 2015  |2 20  |o 10147 
856 4 0 |u https://doi.org/10.1007/s10147-014-0712-4  |q text/html  |z Onlinezugriff via DOI 
898 |a BK010053  |b XK010053  |c XK010000 
900 7 |a Metadata rights reserved  |b Springer special CC-BY-NC licence  |2 nationallicence 
908 |D 1  |a research-article  |2 jats 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-springer 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1007/s10147-014-0712-4  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Santa-Maria  |D Cesar  |u Department of Medical Oncology, Sidney Kimmel Comprehensive Cancer Center, Bunting-Blaustein Cancer Research Bldg, Johns Hopkins University, 1650 Orleans St., Rm. 144, 21287-0013, Baltimore, MD, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Yan  |D Jingsheng  |u Department of Clinical Sciences, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, 75390-8551, Dallas, TX, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Xie  |D Xian-Jin  |u Department of Clinical Sciences, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, 75390-8551, Dallas, TX, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Euhus  |D David  |u Department of Surgery, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, 600 N. Wolfe Street, 21287, Baltimore, MD, USA  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t International Journal of Clinical Oncology  |d Springer Japan  |g 20/2(2015-04-01), 317-323  |x 1341-9625  |q 20:2<317  |1 2015  |2 20  |o 10147